The North America Urology Supplements Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030).
The US market dominated the North America Urology Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $637.6 million by 2030. The Canada market is experiencing a CAGR of 9.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.5% during (2023 - 2030).
Urology supplements' increasing availability and diversity have made them more accessible to consumers. Supplements targeting various urological concerns, such as prostate health, urinary tract support, and sexual function, are readily available in pharmacies, health food stores, online retailers, and other channels. The wide range of formulations, dosages, and delivery formats cater to diverse consumer preferences and needs, further driving adoption. Growing interest in personalized nutrition and lifestyle optimization has led to the popularity of customized supplementation regimens.
There is a growing trend towards integrating nutraceuticals with pharmaceutical interventions in the management of urological disorders. Combination therapies that combine pharmaceutical drugs with complementary nutraceuticals are being explored for their potential synergistic effects and improved therapeutic outcomes. This convergence of conventional medicine and supplementation reflects a holistic approach to urological health, emphasizing comprehensive management strategies that encompass both pharmacological and nutritional interventions.
As the population in Canada ages, the prevalence of urological conditions like urinary tract infections (UTIs), benign prostatic hyperplasia (BPH), kidney stones, and erectile dysfunction tends to rise. According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.
Free Valuable Insights: The Urology Supplements Market is Predict to reach USD 2.6 Billion by 2030, at a CAGR of 7.8%
Based on Type, the market is segmented into Multi-ingredient and Single-ingredient. Based on Distribution Channel, the market is segmented into Brick & Mortar and E-commerce. Based on Application, the market is segmented into Urinary Tract infections, Prostate Health, Bladder Health, and Kidney Health. Based on Formulation, the market is segmented into Capsules, Tablets, Softgels, Liquid and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Type
By Distribution Channel
By Application
By Formulation
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
